title: Type 2 Diabetes Medication Review.
abstract: BACKGROUND
  Patients with type 2 diabetes and their healthcare providers have a variety of medication options available for treating elevated blood glucose values. These medication choices have expanded drastically over the last 10 years with a large number of glucose lowering medications gaining FDA approval.
  
  
  METHODS
  Here, we have included an extensive search of the type 2 diabetes literature focusing on articles which impact patient-oriented evidence that maters (POEMs).
  
  
  RESULTS
  Choosing the best agent(s) can be challenging and requires weighing the risks and benefits of each particular medication. Tailoring medications to individual patients should be prioritized based on trials with cardiovascular outcome data, potential hemoglobin A1c reduction/goal, serious medication precautions and side-effects, co-morbid medical conditions, and cost.
  
  
  CONCLUSIONS
  This paper will provide the reader with an overview of the pros and cons for each antiglycemic medication class and specific drugs where appropriate. Data relevant to most patient centered encounters will be provided, including safety, tolerability, efficacy, cost, and simplicity of use.
authors.affiliation: South Carolina College of Pharmacy, Charleston, South Carolina. Electronic address: sterrejj@musc.edu.
authors.forename: James J
authors.initials: JJ
authors.lastname: Sterrett
authors.affiliation: South Carolina College of Pharmacy, Charleston, South Carolina.
authors.forename: Scott
authors.initials: S
authors.lastname: Bragg
authors.affiliation: South Carolina College of Pharmacy, Charleston, South Carolina.
authors.forename: Charles Wayne
authors.initials: CW
authors.lastname: Weart
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000069472:Colesevelam Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D017723:Drug Utilization Review / Q000379:methods* / Q000592:standards; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000924:Anticholesteremic Agents; D007004:Hypoglycemic Agents; D007328:Insulin; D000069472:Colesevelam Hydrochloride
keywords: Medications; Newer drugs; Pharmacotherapy; Systemic review; Type 2 diabetes